We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Nanotechnology Advances May Transform Regenerative Medicine

By Biotechdaily staff writers
Posted on 03 Oct 2006
Recent nanotechnologic advances in regenerative medicine are propelling it into the forefront of medical developments.

Two studies on the new advances were presented on September 11, 2006, in San Francisco (CA, USA) during the American Chemical Society's 232nd national meeting. More...
Researchers are utilizing nanotubes to transform adult stem cells into neurons in brain-damaged rats. Carbon nanotubes--80,000 times thinner than a human hair--have been shown to enhance the ability of adult stem cells to differentiate into healthy neurons in stroke-damaged rat brains, according to American and South Korean researchers.

Thomas Webster, Ph.D., from Brown University (Providence, RI, USA) and colleagues at Yonsei University (Seoul, Korea), combined nanotubes with adult rat stem cells and then implanted the mixture into brain-damaged areas of three rats that had suffered strokes. In six other rats that had strokes, they implanted either adult stem cells or nanotubes, but not both, into brain-injured regions.

After tracking the rats for up to eight weeks, the researchers concluded that neither nanotubes nor adult stem cells alone activated regeneration or repair in the brain-damaged regions. In reality, when used alone, adult stem cells migrated to healthy areas of the brain. However, when combined with nanotubes, adult stem cells not only remained in the brain-damaged regions, they started to differentiate into functioning neurons. This finding could have significant implications for the treatment of Alzheimer's, Parkinson's disease, and other neurologic disorders, according to Dr. Webster.

In a similar study, researchers injected nanoparticles into the hearts of mice that suffered heart attacks, which helped restore cardiovascular function in these animals, according to Samuel Stupp, Ph.D., chemist and director of the Institute of Bionanotechnology in Medicine at Northwestern University (Evanston, IL, USA). This discovery is an important research development that one day could help rapidly restore cardiovascular function in individuals who have heart disease, according to Dr. Stupp.

The self-assembling nanoparticles--composed from naturally occurring polysaccharides and molecules known as peptide amphiphiles--enhance chemical signals to neighboring cells that trigger formation of new blood vessels, and this may be the mechanism through which they restore cardiovascular function.

One month later, the hearts of the treated mice were capable of contracting and pumping blood almost as well as healthy mice. In contrast, the hearts of untreated mice contracted about 50% less than normal. In other recent studies using a similar technique, Dr. Stupp and his colleagues discovered that nanoparticles accelerate wound-healing in rabbits, and after islet transplantation, cured diabetes in mice. Nanoparticles used with other chemical compounds were found to hasten bone repair in rats and promote the growth of neurons in mice and rats with spinal cord injuries, according to Dr. Stupp.



Related Links:
Brown University
Yonsei University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.